However, in contrast to aHUS, where 63% of CFHR3–1 deficient patients are anti-FH positive (33), only 9% of FHR1 deficient SLE patients in our cohort tested positive for anti-FH. Here, CFHR3 is linked to systemic lupus erythematosus.